Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Follicular 3Asthma 2Pulmonary Disease, Chronic Obstructive 1Carcinoma, Bronchogenic 1Bronchial Hyperreactivity 1

Interventions

Carboplatin 12Pemetrexed 8pembrolizumab 4Paclitaxel 4Cisplatin 4durvalumab 3Radiosurgery 3Gemcitabine 3selpercatinib 2pralsetinib 2osimertinib 2camrelizumab 2atezolizumab 2Docetaxel 2repotrectinib 1motexafin gadolinium 1exemestane 1entinostat 1ceralasertib 1cemiplimab 1belinostat 1belagenpumatucel L 1alectinib 1Vinorelbine 1Tyrosine Kinase Inhibitors 1TNFSF10 protein, human 1Radiotherapy 1Platinum Compounds 1Oncolytic Virotherapy 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Bronchogenic × Fluticasone × Clear all
NCT00407264 2006-12-04

Randomized Trial of Fluticasone in Bronchial Premalignancy

Amsterdam UMC, location VUmc

Phase 2 Completed
90 enrolled

Carcinoma, Bronchogenic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡